NDC 71335-3152 – Buprenorphine

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-3152

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA201760
Marketed since
February 17, 2016
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (10)

Package NDCDescriptionSince
71335-3152-0120 TABLET in 1 BOTTLE (71335-3152-0)Jun 29, 2026
71335-3152-190 TABLET in 1 BOTTLE (71335-3152-1)Jun 29, 2026
71335-3152-260 TABLET in 1 BOTTLE (71335-3152-2)Jun 29, 2026
71335-3152-330 TABLET in 1 BOTTLE (71335-3152-3)Jun 29, 2026
71335-3152-420 TABLET in 1 BOTTLE (71335-3152-4)Jun 29, 2026
71335-3152-57 TABLET in 1 BOTTLE (71335-3152-5)Jun 29, 2026
71335-3152-628 TABLET in 1 BOTTLE (71335-3152-6)Jun 29, 2026
71335-3152-71 TABLET in 1 BOTTLE (71335-3152-7)Jun 29, 2026
71335-3152-812 TABLET in 1 BOTTLE (71335-3152-8)Jun 29, 2026
71335-3152-914 TABLET in 1 BOTTLE (71335-3152-9)Jun 29, 2026

Other Buprenorphine products